237 related articles for article (PubMed ID: 21215784)
1. Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation.
Koay LB; Feng IC; Sheu MJ; Kuo HT; Lin CY; Chen JJ; Wang SL; Tang LY; Tsai SL
Hum Immunol; 2011 Sep; 72(9):687-98. PubMed ID: 21215784
[TBL] [Abstract][Full Text] [Related]
2. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
Feng IC; Koay LB; Sheu MJ; Kuo HT; Sun CS; Lee C; Chuang WL; Liao SK; Wang SL; Tang LY; Cheng CJ; Tsai SL
J Biomed Sci; 2007 Jan; 14(1):43-57. PubMed ID: 17109186
[TBL] [Abstract][Full Text] [Related]
3. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
[TBL] [Abstract][Full Text] [Related]
4. Antigen-induced regulatory T cells in HBV chronically infected patients.
Barboza L; Salmen S; Goncalves L; Colmenares M; Peterson D; Montes H; Cartagirone R; Gutiérrez Mdel C; Berrueta L
Virology; 2007 Nov; 368(1):41-9. PubMed ID: 17643462
[TBL] [Abstract][Full Text] [Related]
5. Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection.
Li X; Chen Y; Ma Z; Ye B; Wu W; Li L
Cell Immunol; 2010; 264(1):42-6. PubMed ID: 20483408
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
8. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
[TBL] [Abstract][Full Text] [Related]
11. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
12. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL
J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662
[TBL] [Abstract][Full Text] [Related]
14. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
[TBL] [Abstract][Full Text] [Related]
15. [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients].
Deng H; Chong YT; Han XY; Zhang FC; Peng XM; Gao ZL; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):721-4. PubMed ID: 17064461
[TBL] [Abstract][Full Text] [Related]
16. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B.
Lin CY; Tsai MC; Huang CT; Hsu CW; Tseng SC; Tsai IF; Chen YC; Yeh CT; Sheen IS; Chien RN
J Viral Hepat; 2007 Jul; 14(7):503-11. PubMed ID: 17576392
[TBL] [Abstract][Full Text] [Related]
17. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
[TBL] [Abstract][Full Text] [Related]
18. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
[TBL] [Abstract][Full Text] [Related]
19. A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies.
Malik IR; Chen A; Brass A; Ahlén G; Rahman M; Sällberg M; Qureshi JA; Frelin L
Scand J Infect Dis; 2012 Jan; 44(1):55-9. PubMed ID: 21933033
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
Stoop JN; Woltman AM; Biesta PJ; Kusters JG; Kuipers EJ; Janssen HL; van der Molen RG
Hepatology; 2007 Sep; 46(3):699-705. PubMed ID: 17654744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
